Midodrine Tillomed

Midodrine, the active ingredient in Midodrine Tillomed, is an Alpha-1 adrenergic agonist presented as an oral tablet for systemic use. It is indicated for the treatment of orthostatic hypotension, helping to raise standing blood pressure in adult patients who experience dizziness or fainting upon standing and may improve overall daily functioning under medical supervision.

GNH USA supplies Midodrine Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with reliable logistics and quality assurance processes.

Midodrine is an antihypotensive agent that acts on the vascular system to counteract low blood pressure.

- Orthostatic hypotension: increases standing blood pressure and reduces dizziness or fainting episodes. - Neurogenic orthostatic hypotension: improves vascular tone in patients with autonomic failure, helping maintain cerebral perfusion. - Postural dizziness due to low blood pressure: raises arterial pressure to alleviate light‑headedness on standing. - Syncope associated with orthostatic drop: supports blood pressure to prevent fainting during positional changes. - Hypotensive episodes in dialysis patients: helps stabilize blood pressure during treatment sessions. - Chronic fatigue syndrome with orthostatic intolerance: may improve standing tolerance and reduce fatigue related to low blood pressure.

Adverse reactions may occur with midodrine therapy and should be monitored.

Common Side Effects: - Piloerection (goose‑bumps): transient skin reaction often seen shortly after dosing. - Itching (pruritus): mild to moderate skin irritation that may occur on the trunk. - Urinary retention: difficulty emptying the bladder, especially in patients with prostate enlargement. - Supine hypertension: elevated blood pressure while lying down, requiring monitoring. - Headache: mild to moderate throbbing sensation commonly reported during therapy.

Serious or Rare Side Effects: - Severe hypertension: rapid and dangerous rise in blood pressure that can lead to stroke. - Allergic reactions: rash, swelling, or anaphylaxis requiring immediate medical attention. - Angioedema: swelling of the face, lips, or throat that may compromise breathing. - Cardiac arrhythmias: irregular heart rhythms potentially precipitated by excessive vasoconstriction.

Careful monitoring and patient education are essential when using midodrine.

- Monitor blood pressure: check supine and standing readings regularly to avoid excessive rise. - Adjust dose cautiously: titrate based on clinical response and tolerability under physician guidance. - Avoid use in patients with severe cardiac disease: risk of excessive vascular constriction. - Consider renal or hepatic impairment: may require dose modification. - Inform healthcare providers of all concomitant medications: to assess interaction risk. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Midodrine can interact with several drug classes, influencing its pressor effect.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other vasopressors (e.g., phenylephrine): additive pressor effect leading to severe hypertension. - Tricyclic antidepressants: may increase pressor response. - Sympathomimetic agents (e.g., ephedrine): heightened risk of dangerous blood pressure elevation.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate orthostatic hypotension if over‑diuresed. - Beta‑blockers: can mask tachycardia that normally accompanies blood pressure changes. - ACE inhibitors or ARBs: may affect overall blood pressure control requiring closer observation.